Efficacy of combination antibiotic therapy including inhaled tobramycin on Burkholderia cepacia pneumonia in a non-cystic fibrosis patient

Burkholderia cepacia complex (BCC) has been recognized as a serious cause of pneumonia in patients with cystic fibrosis. BCC infection has also been reported in non-cystic fibrosis patients. Notably, the mortality rate of bacterial pneumonia caused by BCC is high. Nonetheless, therapeutic management...

Full description

Bibliographic Details

Published in:	IDCases
Main Authors:	Yasuhito Suzuki, Tomoyoshi Lee, Ryuichi Togawa, Riko Sato, Ryuki Yamada, Hikaru Tomita, Natsumi Watanabe, Takaya Kawamata, Mami Rikimaru, Julia Morimoto, Yuki Sato, Hiroyuki Minemura, Takefumi Nikaido, Junpei Saito, Kenya Kanazawa, Yoshinori Tanino, Yoko Shibata
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Subjects:	Burkholderia cepacia complex Pneumonia Tobramycin Non-cystic fibrosis Management
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214250924001574